Resistance characteristics of influenza to amino-adamantyls

Biochimica et Biophysica Acta - Biomembranes

Volumn 1808, Issue 2, 2011, Pages 547-553

  Astrahan, Peleg ^a   Arkin, Isaiah T ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Channel blockers; Influenza; M2 channel; Viral resistance

Indexed keywords

ADAMANTANE DERIVATIVE; AMANTADINE; AMINO ADAMANTYL DERIVATIVE; HEMAGGLUTININ; PROTEIN M2; RIMANTADINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIVIRAL RESISTANCE; BINDING AFFINITY; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG TARGETING; GENETIC VARIABILITY; HUMAN; INFLUENZA; INFLUENZA VIRUS; MUTATION RATE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN STRUCTURE; REVIEW; VIRUS MUTATION; VIRUS RESISTANCE; VIRUS VIABILITY;

ADAMANTANE; AMANTADINE; AMINO ACID SEQUENCE; DRUG RESISTANCE, VIRAL; GENES, VIRAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; ION CHANNELS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN STABILITY; PROTEIN STRUCTURE, TERTIARY; RIMANTADINE; SEQUENCE HOMOLOGY, AMINO ACID; VIRAL MATRIX PROTEINS;

AVES; ORTHOMYXOVIRIDAE; SUIDAE;

EID: 78650290518     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2010.06.018     Document Type: Review

References (58)

1. N.P.A.S. Johnson, and J. Mueller Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic Bull. Hist. Med. 76 2002 105 115
2. A. Trampuz, R.M. Prabhu, T.F. Smith, and L.M. Baddour Avian influenza: a new pandemic threat? Mayo Clin. Proc. 79 4 2004 523 530 quiz 530
3. G. Neumann, T. Noda, and Y. Kawaoka Emergence and pandemic potential of swine-origin H1N1 influenza virus Nature 459 7249 2009 931 939
4. C.Q. He, G.Z. Han, D. Wang, W. Liu, G.R. Li, X.P. Liu, and N.Z. Ding Homologous recombination evidence in human and swine influenza A viruses Virology 380 2008 12 20
5. A. Lackenby, C.I. Thompson, and J. Democratis The potential impact of neuraminidase inhibitor resistant influenza Curr. Opin. Infect. Dis. 21 6 2008 626 638
6. L.H. Pinto, and R.A. Lamb The M2 proton channels of influenza A and B viruses J. Biol. Chem. 281 14 2006 8997 9000
7. L.H. Pinto, and R.A. Lamb Influenza virus proton channels Photochem. Photobiol. Sci. 5 6 2006 629 632
8. D.J. Alexander An overview of the epidemiology of avian influenza A and B viruses Vaccine 25 30 2007 5637 5644
9. A.J. Hay, A.J. Wolstenholme, J.J. Skehel, and M.H. Smith The molecular basis of the specific anti-influenza action of amantadine EMBO J. 4 11 1985 3021 3024
10. L.H. Pinto, L.J. Holsinger, and R.A. Lamb Influenza virus M2 protein has ion channel activity Cell 69 3 1992 517 528
11. A. Helenius Unpacking the incoming influenza virus Cell 69 4 1992 577 578
12. T. Sakaguchi, Q. Tu, L.H. Pinto, and R.A. Lamb The active oligomeric state of the minimalistic influenza virus M2 ion channel is a tetramer Proc. Nat. Acad. Sci. U.S.A. 94 10 1997 5000 5005
13. L.J. Holsinger, and R.A. Lamb Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds Virology 183 1991 32 43
14. K.C. Duff, and R.H. Ashley The transmembrane domain of influenza A M2 protein forms amantadine-sensitive proton channels in planar lipid bilayers Virology 190 1992 485 489
15. A.L. Stouffer, R. Acharya, D. Salom, A.S. Levine, L. Di Costanzo, C.S. Soto, V. Tereshko, V. Nanda, S. Stayrook, and W.F. DeGrado Structural basis for the function and inhibition of an influenza virus proton channel Nature 451 7178 2008 596 599
16. K. Nishimura, S. Kim, L. Zhang, and T.A. Cross The closed state of a H+ channel helical bundle combining precise orientational and distance restraints from solid state NMR Biochemistry 41 44 2002 13170 13177
17. J.R. Schnell, and J.J. Chou Structure and mechanism of the M2 proton channel of influenza A virus Nature 451 7178 2008 591 595
18. J. Manor, P. Mukherjee, Y.S. Lin, H. Leonov, J.L. Skinner, M.T. Zanni, and I.T. Arkin Gating mechanism of the influenza A M2 channel revealed by 1D and 2D IR spectroscopies Structure 17 2 2009 247 254
19. R.M. Pielak, J.J. Chou: Influenza M2 proton channels. Biochem Biophys Acta 2010.
20. R.M. Pielak, J.R. Schnell, and J.J. Chou Mechanism of drug inhibition and drug resistance of influenza A M2 channel Proc. Nat. Acad. Sci. U.S.A. 106 18 2009 7379 7384
21. A.L. Stouffer, C. Ma, L. Cristian, Y. Ohigashi, R.A. Lamb, J.D. Lear, L.H. Pinto, and W.F. DeGrado The interplay of functional tuning, drug resistance, and thermodynamic stability in the evolution of the M2 proton channel from the influenza A virus Structure 16 7 2008 1067 1076
22. X. Jing, C. Ma, Y. Ohigashi, F.A. Oliveira, T.S. Jardetzky, L.H. Pinto, and R.A. Lamb Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel Proc. Nat. Acad. Sci. U.S.A 105 31 2008 10967 10972
23. K.C. Duff, S.M. Kelly, N.C. Price, and J.P. Bradshaw The secondary structure of influenza A M2 transmembrane domain. A circular dichroism study FEBS Lett. 311 3 1992 256 258
24. F.A. Kovacs, and T.A. Cross Transmembrane four-helix bundle of influenza A M2 protein channel: structural implications from helix tilt and orientation Biophys. J. 73 5 1997 2511 2517
25. A. Kukol, and I.T. Arkin vpu transmembrane peptide structure obtained by site-specific fourier transform infrared dichroism and global molecular dynamics searching Biophys. J. 77 3 1999 1594 1601
26. T.M. Sweet, H.F. Maassab, K. Coelingh, and M.L. Herlocher Creation of amantadine resistant clones of influenza type A virus using a new transfection procedure J. Virol. Meth. 69 1-2 1997 103 111
27. R.G. Webster, W.J. Bean, O.T. Gorman, T.M. Chambers, and Y. Kawaoka Evolution and ecology of influenza A viruses Microbiol. Rev. 56 1992 152 179
28. N.A. Ilyushina, E.A. Govorkova, and R.G. Webster Detection of amantadine-resistant variants among avian influenza viruses isolated in North America and Asia Virology 341 2005 102 106
29. A. Krumbholz, M. Schmidtke, S. Bergmann, S. Motzke, K. Bauer, J. Stech, R. Dürrwald, P. Wutzler, and R. Zell High prevalence of amantadine resistance among circulating European porcine influenza A viruses J. Gen. Virol. 90 Pt 4 2009 900 908
30. C.L. Cheung, J.M. Rayner, G.J.D. Smith, P. Wang, T.S.P. Naipospos, J. Zhang, K.Y. Yuen, R.G. Webster, J.S.M. Peiris, Y. Guan, and H. Chen Distribution of amantadine-resistant H5N1 avian influenza variants in Asia J. Infect. Dis. 193 12 2006 1626 1629
31. J. Lee, Y.J. Song, J.H. Park, J.H. Lee, Y.H. Baek, M.S. Song, T.K. Oh, H.S. Han, P.N.Q. Pascua, and Y.K. Choi Emergence of amantadine-resistant H3N2 avian influenza A virus in South Korea J. Clin. Microbiol. 46 11 2008 3788 3790
32. Y. Guan, L.L.M. Poon, C.Y. Cheung, T.M. Ellis, W. Lim, A.S. Lipatov, K.H. Chan, K.M. Sturm-Ramirez, C.L. Cheung, Y.H.C. Leung, K.Y. Yuen, R.G. Webster, and J.S.M. Peiris H5N1 influenza: a protean pandemic threat Proc. Nat. Acad. Sci. U.S.A. 101 21 2004 8156 8161
33. K.S. Li, Y. Guan, J. Wang, G.J.D. Smith, K.M. Xu, L. Duan, A.P. Rahardjo, P. Puthavathana, C. Buranathai, T.D. Nguyen, A.T.S. Estoepangestie, A. Chaisingh, P. Auewarakul, H.T. Long, N.T.H. Hanh, R.J. Webby, L.L.M. Poon, H. Chen, K.F. Shortridge, K.Y. Yuen, R.G. Webster, and J.S.M. Peiris Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia Nature 430 6996 2004 209 213
34. J. Parry Use of antiviral drug in poultry is blamed for drug resistant strains of avian flu BMJ 331 7507 2005 10
35. L. Simonsen, C. Viboud, B.T. Grenfell, J. Dushoff, L. Jennings, M. Smit, C. Macken, M. Hata, J. Gog, M.A. Miller, and E.C. Holmes The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance Mol. Biol. Evol. 24 8 2007 1811 1820
36. Centers for Disease Control and Prevention (CDC): Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR Morb Mortal Wkly Rep 2009, 58(16):433-435.
37. R. Saito, T. Sakai, I. Sato, Y. Sano, H. Oshitani, M. Sato, and H. Suzuki Frequency of amantadine-resistant influenza A viruses during two seasons featuring cocirculation of H1N1 and H3N2 J. Clin. Microbiol. 41 5 2003 2164 2165
38. Y. Abed, N. Goyette, and G. Boivin Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations Antimicrob. Agents Chemother. 49 2 2005 556 559
39. P. Astrahan, I. Kass, M.A. Cooper, and I.T. Arkin A novel method of resistance for influenza against a channel-blocking antiviral drug Proteins 55 2 2004 251 257
40. L.J. Holsinger, D. Nichani, L.H. Pinto, and R.A. Lamb Influenza A virus M2 ion channel protein: a structure-function analysis J. Virol. 68 3 1994 1551 1563
41. C. Wang, K. Takeuchi, L.H. Pinto, and R.A. Lamb Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block J. Virol. 67 9 1993 5585 5594
42. V. Balannik, P. Obrdlik, S. Inayat, C. Steensen, J. Wang, J.M. Rausch, W.F. DeGrado, B. Kelety, and L.H. Pinto Solid-supported membrane technology for the investigation of the influenza A virus M2 channel activity Pflugers Arch. 459 4 2010 593 605
43. S. Grambas, M.S. Bennett, and A.J. Hay Influence of amantadine resistance mutations on the pH regulatory function of the M2 protein of influenza A viruses Virology 191 2 1992 541 549
44. K. Shiraishi, K. Mitamura, Y. Sakai-Tagawa, H. Goto, N. Sugaya, and Y. Kawaoka High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza J. Infect. Dis. 188 2003 57 61
45. P. Astrahan, R. Flitman-Tene, E.R. Bennett, M. Krugliak, C. Gilon, I.T. Arkin: a rapid, accurate and economic method to identify channel inhibitors demonstrated on influenza M2.
46. C. Ma, A.L. Polishchuk, Y. Ohigashi, A.L. Stouffer, A. Schön, E. Magavern, X. Jing, J.D. Lear, E. Freire, R.A. Lamb, W.F. DeGrado, and L.H. Pinto Identification of the functional core of the influenza A virus A/M2 proton-selective ion channel Proc. Nat. Acad. Sci. U.S.A. 106 30 2009 12283 12288
47. I.V. Chizhmakov, D.C. Ogden, F.M. Geraghty, A. Hayhurst, A. Skinner, T. Betakova, and A.J. Hay Differences in conductance of M2 proton channels of two influenza viruses at low and high pH J. Physiol. 546 Pt 2 2003 427 438
48. R.S. Daniels, J.C. Downie, A.J. Hay, M. Knossow, J.J. Skehel, M.L. Wang, and D.C. Wiley Fusion mutants of the influenza virus hemagglutinin glycoprotein Cell 40 2 1985 431 439
49. D.A. Steinhauer, S.A. Wharton, J.J. Skehel, D.C. Wiley, and A.J. Hay Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: evidence for virus-specific regulation of the pH of glycoprotein transport vesicles Proc. Nat. Acad. Sci. U.S.A. 88 24 1991 11525 11529
50. N.A. Ilyushina, E.A. Govorkova, C.J. Russell, E. Hoffmann, and R.G. Webster Contribution of H7 haemagglutinin to amantadine resistance and infectivity of influenza virus J. Gen. Virol. 88 Pt 4 2007 1266 1274
51. J.J. Skehel, P.M. Bayley, E.B. Brown, S.R. Martin, M.D. Waterfield, J.M. White, I.A. Wilson, and D.C. Wiley Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion Proc. Nat. Acad. Sci. U.S.A. 79 4 1982 968 972
52. F. Ciampor, P.M. Bayley, M.V. Nermut, E.M. Hirst, R.J. Sugrue, and A.J. Hay Evidence that the amantadine-induced, M2-mediated conversion of influenza A virus hemagglutinin to the low pH conformation occurs in an acidic trans Golgi compartment Virology 188 1992 14 24
53. S.G. Lazarowitz, and P.W. Choppin Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide Virology 68 2 1975 440 454
54. R.J. Sugrue, G. Bahadur, M.C. Zambon, M. Hall-Smith, A.R. Douglas, and A.J. Hay Specific structural alteration of the influenza haemagglutinin by amantadine EMBO J. 9 11 1990 3469 3476
55. S. Ohkuma, and B. Poole Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents Proc. Nat. Acad. Sci. U.S.A. 75 7 1978 3327 3331
56. A. Yoshimura, K. Kuroda, K. Kawasaki, S. Yamashina, T. Maeda, and S. Ohnishi Infectious cell entry mechanism of influenza virus J. Virol. 43 1982 284 293
57. D. Li, R. Saito, Y. Suzuki, I. Sato, H. Zaraket, C. Dapat, I.M. Caperig-Dapat, and H. Suzuki In vivo and in vitro alterations in influenza A/H3N2 virus M2 and hemagglutinin genes: effect of passage in MDCK-SIAT1 cells and conventional MDCK cells J. Clin. Microbiol. 47 2 2009 466 468
58. E. Nobusawa, and K. Sato Comparison of the mutation rates of human influenza A and B viruses J. Virol. 80 7 2006 3675 3678